These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 33749332)

  • 1. Osteocyte- and late osteoblast-derived NOTUM reduces cortical bone mass in mice.
    Nilsson KH; Henning P; El Shahawy M; Wu J; Koskela A; Tuukkanen J; Perret C; Lerner UH; Ohlsson C; Movérare-Skrtic S
    Am J Physiol Endocrinol Metab; 2021 May; 320(5):E967-E975. PubMed ID: 33749332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoblast-derived NOTUM reduces cortical bone mass in mice and the
    Movérare-Skrtic S; Nilsson KH; Henning P; Funck-Brentano T; Nethander M; Rivadeneira F; Coletto Nunes G; Koskela A; Tuukkanen J; Tuckermann J; Perret C; Souza PPC; Lerner UH; Ohlsson C
    FASEB J; 2019 Oct; 33(10):11163-11179. PubMed ID: 31307226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutive protein kinase A activity in osteocytes and late osteoblasts produces an anabolic effect on bone.
    Kao RS; Abbott MJ; Louie A; O'Carroll D; Lu W; Nissenson R
    Bone; 2013 Aug; 55(2):277-87. PubMed ID: 23583750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone Mass and Strength are Significantly Improved in Mice Overexpressing Human WNT16 in Osteocytes.
    Alam I; Reilly AM; Alkhouli M; Gerard-O'Riley RL; Kasipathi C; Oakes DK; Wright WB; Acton D; McQueen AK; Patel B; Lim KE; Robling AG; Econs MJ
    Calcif Tissue Int; 2017 Apr; 100(4):361-373. PubMed ID: 28013361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Notum Deletion From Late-Stage Skeletal Cells Increases Cortical Bone Formation and Potentiates Skeletal Effects of Sclerostin Inhibition.
    Choi RB; Bullock WA; Hoggatt AM; Horan DJ; Pemberton EZ; Hong JM; Zhang X; He X; Robling AG
    J Bone Miner Res; 2021 Dec; 36(12):2413-2425. PubMed ID: 34223673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptor-α in osteocytes is important for trabecular bone formation in male mice.
    Windahl SH; Börjesson AE; Farman HH; Engdahl C; Movérare-Skrtic S; Sjögren K; Lagerquist MK; Kindblom JM; Koskela A; Tuukkanen J; Divieti Pajevic P; Feng JQ; Dahlman-Wright K; Antonson P; Gustafsson JÅ; Ohlsson C
    Proc Natl Acad Sci U S A; 2013 Feb; 110(6):2294-9. PubMed ID: 23345419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of Gsα in osteocytes leads to osteopenia due to sclerostin induced suppression of osteoblast activity.
    Fulzele K; Dedic C; Lai F; Bouxsein M; Lotinun S; Baron R; Divieti Pajevic P
    Bone; 2018 Dec; 117():138-148. PubMed ID: 30266511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteocyte network; a negative regulatory system for bone mass augmented by the induction of Rankl in osteoblasts and Sost in osteocytes at unloading.
    Moriishi T; Fukuyama R; Ito M; Miyazaki T; Maeno T; Kawai Y; Komori H; Komori T
    PLoS One; 2012; 7(6):e40143. PubMed ID: 22768243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTH receptor signaling in osteocytes governs periosteal bone formation and intracortical remodeling.
    Rhee Y; Allen MR; Condon K; Lezcano V; Ronda AC; Galli C; Olivos N; Passeri G; O'Brien CA; Bivi N; Plotkin LI; Bellido T
    J Bone Miner Res; 2011 May; 26(5):1035-46. PubMed ID: 21140374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Notch signaling in osteocytes differentially regulates cancellous and cortical bone remodeling.
    Canalis E; Adams DJ; Boskey A; Parker K; Kranz L; Zanotti S
    J Biol Chem; 2013 Aug; 288(35):25614-25625. PubMed ID: 23884415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditional deletion of Pkd1 in osteocytes disrupts skeletal mechanosensing in mice.
    Xiao Z; Dallas M; Qiu N; Nicolella D; Cao L; Johnson M; Bonewald L; Quarles LD
    FASEB J; 2011 Jul; 25(7):2418-32. PubMed ID: 21454365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twist1 Inactivation in Dmp1-Expressing Cells Increases Bone Mass but Does Not Affect the Anabolic Response to Sclerostin Neutralization.
    Lewis KJ; Choi RB; Pemberton EZ; Bullock WA; Firulli AB; Robling AG
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31505764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estradiol and RSPO3 regulate vertebral trabecular bone mass independent of each other.
    Nilsson KH; Wu J; Gustafsson KL; El Shahawy M; Koskela A; Tuukkanen J; Tuckermann J; Henning P; Lerner UH; Ohlsson C; Movérare-Skrtic S
    Am J Physiol Endocrinol Metab; 2022 Mar; 322(3):E211-E218. PubMed ID: 35068191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inducible
    Ohlsson C; Henning P; Nilsson KH; Wu J; Gustafsson KL; Sjögren K; Törnqvist A; Koskela A; Zhang FP; Lagerquist MK; Poutanen M; Tuukkanen J; Lerner UH; Movérare-Skrtic S
    J Endocrinol; 2018 May; 237(2):113-122. PubMed ID: 29530924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the type 1 lysophosphatidic acid receptor in osteoblastic cell lineage controls both bone mineralization and osteocyte specification.
    Alioli CA; Demesmay L; Laurencin-Dalacieux S; Beton N; Farlay D; Follet H; Saber A; Duboeuf F; Chun J; Rivera R; Bouvard D; Machuca-Gayet I; Salles JP; Gennero I; Peyruchaud O
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Aug; 1865(8):158715. PubMed ID: 32330664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteocyte Death and Bone Overgrowth in Mice Lacking Fibroblast Growth Factor Receptors 1 and 2 in Mature Osteoblasts and Osteocytes.
    McKenzie J; Smith C; Karuppaiah K; Langberg J; Silva MJ; Ornitz DM
    J Bone Miner Res; 2019 Sep; 34(9):1660-1675. PubMed ID: 31206783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of Notch3 in osteoblasts/osteocytes causes compartment-specific changes in bone remodeling.
    Canalis E; Zanotti S; Schilling L; Eller T; Yu J
    J Biol Chem; 2021; 296():100583. PubMed ID: 33774049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures.
    Movérare-Skrtic S; Henning P; Liu X; Nagano K; Saito H; Börjesson AE; Sjögren K; Windahl SH; Farman H; Kindlund B; Engdahl C; Koskela A; Zhang FP; Eriksson EE; Zaman F; Hammarstedt A; Isaksson H; Bally M; Kassem A; Lindholm C; Sandberg O; Aspenberg P; Sävendahl L; Feng JQ; Tuckermann J; Tuukkanen J; Poutanen M; Baron R; Lerner UH; Gori F; Ohlsson C
    Nat Med; 2014 Nov; 20(11):1279-88. PubMed ID: 25306233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of the auxiliary α2δ1 voltage sensitive calcium channel subunit in osteocytes and late-stage osteoblasts impairs femur strength and load-induced bone formation in male mice.
    Wright CS; Lewis KJ; Semon K; Yi X; Reyes Fernandez PC; Rust K; Prideaux M; Schneider A; Pederson M; Deosthale P; Plotkin LI; Hum JM; Sankar U; Farach-Carson MC; Robling AG; Thompson WR
    J Bone Miner Res; 2024 Apr; 39(3):298-314. PubMed ID: 38477790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prednisolone induces osteocytes apoptosis by promoting Notum expression and inhibiting PI3K/AKT/GSK3β/β-catenin pathway.
    Li C; Yang P; Liu B; Bu J; Liu H; Guo J; Hasegawa T; Si H; Li M
    J Mol Histol; 2021 Oct; 52(5):1081-1095. PubMed ID: 34297260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.